Pherecydes Pharma Société anonyme ALPHE.PA Stock
Pherecydes Pharma Société anonyme Price Chart
Pherecydes Pharma Société anonyme ALPHE.PA Financial and Trading Overview
| Pherecydes Pharma Société anonyme stock price | 1.96 EUR |
| Previous Close | 1.95 EUR |
| Open | 1.98 EUR |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 1.98 - 1.99 EUR |
| 52 Week Range | 1.72 - 4.49 EUR |
| Volume | 1.01K EUR |
| Avg. Volume | 9.7K EUR |
| Market Cap | 15.76M EUR |
| Beta (5Y Monthly) | 0.985797 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6 EUR |
ALPHE.PA Valuation Measures
| Enterprise Value | 12.63M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.547987 |
| Price/Book (mrq) | 1.4103472 |
| Enterprise Value/Revenue | 3.645 |
| Enterprise Value/EBITDA | -2.825 |
Trading Information
Pherecydes Pharma Société anonyme Stock Price History
| Beta (5Y Monthly) | 0.985797 |
| 52-Week Change | -55.68% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.49 EUR |
| 52 Week Low | 1.72 EUR |
| 50-Day Moving Average | 2.28 EUR |
| 200-Day Moving Average | 2.31 EUR |
ALPHE.PA Share Statistics
| Avg. Volume (3 month) | 9.7K EUR |
| Avg. Daily Volume (10-Days) | 9.83K EUR |
| Shares Outstanding | 7.92M |
| Float | 2.67M |
| Short Ratio | N/A |
| % Held by Insiders | 9.55% |
| % Held by Institutions | 54.48% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -80.61% |
| Operating Margin (ttm) | -133.72% |
| Gross Margin | -18.85% |
| EBITDA Margin | -129.037% |
Management Effectiveness
| Return on Assets (ttm) | -19.90% |
| Return on Equity (ttm) | -29.056% |
Income Statement
| Revenue (ttm) | 3.46M EUR |
| Revenue Per Share (ttm) | 0.59 EUR |
| Quarterly Revenue Growth (yoy) | 102.79% |
| Gross Profit (ttm) | -806458 EUR |
| EBITDA | -4470081 EUR |
| Net Income Avi to Common (ttm) | -2792540 EUR |
| Diluted EPS (ttm) | -0.79 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.21M EUR |
| Total Cash Per Share (mrq) | 0.21 EUR |
| Total Debt (mrq) | 2.39M EUR |
| Total Debt/Equity (mrq) | 28.84 EUR |
| Current Ratio (mrq) | 1.735 |
| Book Value Per Share (mrq) | 1.411 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Pherecydes Pharma Société anonyme
| Country | France |
| State | N/A |
| City | Romainville |
| Address | 102 avenue Gaston Roussel |
| ZIP | 93230 |
| Phone | 33 1 48 40 65 35 |
| Website | https://www.pherecydes-pharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 27 |
Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-staphylococcus aureus for the treatment of bone/joint and diabetic foot ulcer infections; anti-pseudomonas aeruginosa, a phage therapy treatment for respiratory tract infections; and anti-escherichia coli for the treatment of respiratory tract infections. The company was founded in 2006 and is headquartered in Romainville, France.
Q&A For Pherecydes Pharma Société anonyme Stock
What is a current ALPHE.PA stock price?
Pherecydes Pharma Société anonyme ALPHE.PA stock price today per share is 1.96 EUR.
How to purchase Pherecydes Pharma Société anonyme stock?
You can buy ALPHE.PA shares on the Paris exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pherecydes Pharma Société anonyme?
The stock symbol or ticker of Pherecydes Pharma Société anonyme is ALPHE.PA.
Which industry does the Pherecydes Pharma Société anonyme company belong to?
The Pherecydes Pharma Société anonyme industry is Biotechnology.
How many shares does Pherecydes Pharma Société anonyme have in circulation?
The max supply of Pherecydes Pharma Société anonyme shares is 7.92M.
What is Pherecydes Pharma Société anonyme Price to Earnings Ratio (PE Ratio)?
Pherecydes Pharma Société anonyme PE Ratio is 0.00000000 now.
What was Pherecydes Pharma Société anonyme earnings per share over the trailing 12 months (TTM)?
Pherecydes Pharma Société anonyme EPS is 0 EUR over the trailing 12 months.
Which sector does the Pherecydes Pharma Société anonyme company belong to?
The Pherecydes Pharma Société anonyme sector is Healthcare.